Diagnostic value of combined serum CEA and CA19-9 in colorectal cancer A meta-analysis
Liushaoqiu Zhou, Songlin An, Yuanzhong Zhou, Yonghong Ma, Guanyu Li, Tao Zhang, Daimin Xiao · 2026
Read Diagnostic value of combined serum CEA and CA19-9 in colorectal cancer A meta-analysis by Liushaoqiu Zhou, Songlin An, Yuanzhong Zhou, Yonghong Ma, Guanyu Li, Tao Zhang, Daimin Xiao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13157001.txt.
Description
Liushaoqiu Zhou and co-authors pool evidence on blood markers for colorectal cancer in this 2026 meta-analysis. Colorectal cancer is a top cause of cancer death, and early detection saves lives. Two serum markers, CEA and CA19-9, are widely used but weak alone.
The analysis covered 95 studies with 22,821 subjects in total. Testing both markers together raised sensitivity well above either one alone. Specificity stayed high for the combined test. The combined odds measure was far stronger than for single markers. Curve and clinical utility analyses backed the paired approach. The authors support adding combined marker testing to routine diagnosis work.
Catalog record
| CREATOR | Liushaoqiu Zhou, Songlin An, Yuanzhong Zhou, Yonghong Ma, Guanyu Li, Tao Zhang, Daimin Xiao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |